Inhibition of fatty acid oxidation by biguanides: implications for metabolic physiopathology.
D000244:Adenosine Diphosphate / Q000378:metabolism; D000255:Adenosine Triphosphate / Q000378:metabolism; D000273:Adipose Tissue / Q000187:drug effects / Q000378:metabolism; D000818:Animals; D001645:Biguanides / Q000494:pharmacology*; D001692:Biological Transport; D002245:Carbon Dioxide / Q000378:metabolism; D002250:Carbon Radioisotopes; D003921:Diabetes Mellitus, Experimental / Q000378:metabolism; D005227:Fatty Acids / Q000378:metabolism*; D005943:Gluconeogenesis / Q000187:drug effects; D005990:Glycerol / Q000378:metabolism; D006003:Glycogen / Q000378:metabolism; D006168:Guinea Pigs; D006801:Humans; D006949:Hyperlipidemias / Q000235:genetics* / Q000378:metabolism*; D007328:Insulin / Q000494:pharmacology; D008099:Liver / Q000187:drug effects / Q000201:enzymology; D008291:Malate Dehydrogenase / Q000378:metabolism; D009132:Muscles / Q000187:drug effects / Q000378:metabolism; D010084:Oxidation-Reduction; D010477:Perfusion; D010629:Phenformin / Q000494:pharmacology; D011766:Pyruvate Carboxylase / Q000378:metabolism; D051381:Rats; D013045:Species Specificity
D001645:Biguanides; D002250:Carbon Radioisotopes; D005227:Fatty Acids; D007328:Insulin; D002245:Carbon Dioxide; D000244:Adenosine Diphosphate; D000255:Adenosine Triphosphate; D006003:Glycogen; D010629:Phenformin; D008291:Malate Dehydrogenase; D011766:Pyruvate Carboxylase; D005990:Glycerol